11-19 更新 实时
首页/ 科技公司/ 正文

Isomorphic Labs六个月内二度融资50亿美元

科技公司 来源:The Decoder 2026-11-17 22:57 0 阅读 机器翻译
Isomorphic Labs六个月内二度融资50亿美元

Alphabet 旗下 AI 药物发现公司 Isomorphic Labs 已融资 50 亿美元,这是其六个月内第二轮十亿美元级融资。Greenoaks 与 Sequoia Capital 联合领投本轮,新投资方 Andreessen Horowitz 以及 Alphabet 和所有现有投资方参投。

该公司早在 2026 年 5 月就已融资 21 亿美元。这笔资金将用于推进其自研平台 IsoDDE(Isomorphic Drug Design Engine,Isomorphic 药物设计引擎),并推动其药物管线走向临床试验。据这家成立于 2021 年的公司称,IsoDDE 超越了 AlphaFold 3,旨在更好地预测药物结合位点和对接位点。Isomorphic Labs 与 Novartis、Eli Lilly 和 Johnson & Johnson 有合作,但迄今还没有一款获批药物可以拿出来。

该公司由 Demis Hassabis 领导,他于 2026 年 8 月卸任 Google Deepmind 的日常领导职务,现担任 Alphabet 首席科学家。Hassabis 与 John Jumper 因在 AlphaFold 上的工作共同获得 2024 年诺贝尔化学奖。

Deepmind 最初的 AlphaFold 团队于 2026 年 7 月被解散。许多研究人员转至 Isomorphic Labs,或被重新分配到其他项目。近四分之一的人完全离开了 Deepmind。Deepmind 仍在 2026 年 11 月初发布了 AlphaGenome 2,该模型可预测 DNA 变异如何影响特定细胞类型中的基因活性。

无炒作的 AI 新闻——由人工精选

译文由英文原文机器翻译,术语按行业惯例统一,可在文末展开原文核对。

查看英文原文(Isomorphic Labs raises $5 billion in its second mega-round within six months)

Alphabet's AI drug discovery company Isomorphic Labs has raised $5 billion, its second billion-dollar round in six months. Greenoaks and Sequoia Capital co-led the round, joined by new backer Andreessen Horowitz along with Alphabet and all existing investors.

The company had already raised $2.1 billion back in May 2026. The money will go toward advancing its in-house platform IsoDDE (Isomorphic Drug Design Engine) and pushing its drug pipeline toward clinical trials. IsoDDE goes beyond AlphaFold 3, according to the company founded in 2021, and aims to better predict drug binding and docking sites. Isomorphic Labs works with Novartis, Eli Lilly, and Johnson & Johnson but has no approved drug to show for it yet.

The company is led by Demis Hassabis, who stepped down from day-to-day leadership of Google Deepmind in August 2026 and now serves as Alphabet's Chief Scientist. Hassabis won the 2024 Nobel Prize in Chemistry alongside John Jumper for their work on AlphaFold.

Deepmind's original AlphaFold team was disbanded in July 2026. Many researchers moved to Isomorphic Labs or were reassigned to other projects. Nearly a quarter left Deepmind entirely. Deepmind still shipped AlphaGenome 2 in early November 2026, which predicts how DNA variants affect gene activity in specific cell types.

AI News Without the Hype – Curated by Humans

原文为英文,正文由自动抓取并保留原文。

本文由采集器自动同步

原文发布于 The Decoder(Isomorphic Labs raises $5 billion in its second mega-round within six months),标题、摘要与正文由机器翻译,术语按行业惯例统一,未经人工逐句校订。

阅读原文 ↗